One granddaughter is making her grandmother’s dream of being a fashion designer come true with the help of TikTok.

Share:
More In Technology
John Deere Unveils Self-Driving Tractor at CES 2022
John Deere is getting on board the autonomous vehicle craze with its own self-driving tractors. The farming and forestry equipment manufacturer made the announcement at the 2022 CES convention in Las Vegas. Jahmy Hindman, chief technology officer at John Deere, spoke to Cheddar about the shift to self-driving to agriculture and how it will help farmers produce even more food as the world's population continues to grow. "It's all about trying to do more with less in farming," he said. "Labor's already a problem on the farm, and it's only getting to be more of a problem in the future. And we really view autonomy as a way to solve that problem."
Mobile Sports Betting Starts in New York on Saturday
It is 'game on' for sports bettors in the state of New York, as mobile betting kicks off on four major betting operating platforms this Saturday. The state, with over 20 million residents, will be the most populous state with legal online sports betting. Max Bichsel, VP of US Business for EmpireStakes.com joins Cheddar News to discuss.
New Executive Order Modernizes Government Services, Top Tech Talent Moves to Federal Government
Far too often, Americans are forced to navigate a tangled web of outdated government websites, offices way out of their reach, and hours of time 'on hold' to access the simple government services they depend on. A recent executive order, signed by President Biden, is intended to improve, streamline and modernize the 'customer' experience when accessing government services. Mina Hsiang, the administrator of the United States Digital Service, joins Cheddar News to discuss how the tech workforce is impacted by this executive order.
Best of CES 2022: A Cheddar News Special
Cheddar has been following all things innovative, fascinating, and downright cool from CES 2022. Watch the full episode, hosted by Cheddar's Ken Buffa and Michelle Castillo.
2021 Sees Record Number of Tech Deals; Will 2022 Bring Even Bigger Tech Investments?
Private equity firms in 2021 spent $401.71 billion in U.S. tech investments — doubling 2020's level of $196.34 billion. As tech becomes increasingly interwoven into our lives amid the pandemic, investors grow bullish on the sector, especially software-as-a-service companies. How will 2022 stack up to 2021, and is there potential for parts of the tech sector to sink this year? John Jannarone, Editor in Chief at IPO-Edge, joins Cheddar News' Closing Bell to discuss 2021's record year of deals, how potential interest rate hikes will impact tech investments in 2022, the fastest-growing IPOs, and more.
Bed Bath & Beyond's Stock Jumps Despite Earnings Miss as Meme Stock Mania Reappears
Bed Bath & Beyond delivered disappointing fiscal third-quarter results for 2022. Shares initially dove more than 9% in premarket trading on the news but finished the day up nearly 8%. Bed Bath & Beyond has been a meme-stock target for online investors in the past -- so was meme-stock mania a factor in the recent stock movement for the company? Jaime Rogozinski, the founder of the subreddit WallStreetBets, joins Cheddar News' Closing Bell for more, as his forum helped spark the meme stock phenomena. He also discussed some decentralized finance services and trends for the retail investor to watch for in 2022.
Pear Therapeutics CEO on How Its Apps Work for Conditions Like Addiction
Digital medical care provider Pear Therapeutics rang the closing bell on the Nasdaq Friday and President and CEO Dr. Corey McCann, joined Cheddar to talk about how the company plans to grow the business of software-based therapeutics and how the first FDA authorized prescription digital therapeutics company will go about treating illnesses like insomnia and addiction. "These really are pieces of software. In many cases, they're apps and in the cases of our addiction products, these are based on something called cognitive behavioral therapy or CBT," he said. "These products change the patient's brain circuitry to help them be abstinent, to help them stay in treatment, and that's exactly what we see in randomized clinical trials and that's what we see in the real world." He also addressed the ongoing mental health crises brought on by the pandemic. **copy updated to remove IPO information as Pear Therapeutics went public in December**
Load More